All Whitepapers

Digital patient solutions: the secret to delivering and securing adoption

October 23, 2020

Industry experts cover how to develop digital patient solutions that address real unmet needs and secure adoption.

Gaining Payer Attention Through Digital Innovation

October 14, 2020

In this case study, learn how to increase payer engagement, drive awareness, monitor competition, and leverage insights to enhance strategic plans and launch success.

Solving access, reimbursement, and PAP awareness problems

October 12, 2020

With bigger patient access and affordability barriers given the new normal of COVID-19, see why field services are more important than ever. Read now.

Patient Support Programs: Considerations for Crisis Management and Risk Mitigation

October 12, 2020

This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.

The Changing Landscape of Biopharma Finance

October 02, 2020

In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising capital or addressing pricing pressures to prioritizing development efforts or managing third-party risks, the landscape of Biopharma Finance is changing.

Manufacturer’s Guide to Omnichannel Marketing

September 18, 2020

With the future of face-to-face field sales uncertain, how can pharma ensure product messaging reaches the right healthcare audiences and, ultimately, patients?

COVID-19 Action Plan for Ethics and Compliance Teams

June 26, 2020

Sponsored Content

Compliance officers from the life sciences industry joined together recently to discuss how the COVID-19 pandemic has changed the ways we live and work, and how those changes have impacted the life sciences industry as a whole and will continue to do so in the future.

Tips for Promoting Drug Update in Hospitals

June 26, 2020

Sponsored Content

Hospitals represent a critical access point for many therapeutics. Whether a therapeutic is indicated for use exclusively in a hospital or in both inpatient and outpatient settings, hospitals are key points of drug initiation or switching. To gain access to this channel, pharma companies must understand the needs and differences of hospital systems.

Connecting and Leveraging Quality-Driven Data

June 18, 2020

MasterControl’s new e-book proves how the adoption of a data-driven and technology-supported approach to product life cycle management differentiates pharma leaders.

Managing the COVID-19 Drug Safety Response

June 08, 2020

Sponsored Content

Current safety reporting systems cannot meet the demands of a COVID-19 response. Find out how digital transformation enables rapid understanding & management of drug safety.

Virtual, Decentralized, Site-less Trials …What Does it All Mean

June 04, 2020

Sponsored Content

Virtual elements in clinical trials require extra considerations All teams involved should maintain ongoing dialogue and collaboration for success A discussion with industry leaders provides insight into such trials

Marketing During the COVID-19 Crisis

May 01, 2020

Sponsored Content

An overview of marketing during the COVID-19 crisis and how to utilize various tactical solutions to successfully reach your targeted healthcare professional audiences.

How to Select the Right Data Partner to Benefit Your Business

April 23, 2020

Sponsored Content

LexisNexis Risk Solutions takes you inside the key considerations of making the all-important choice to partner with a data provider. Go beyond the well-polished sales pitches and understand the underlying implication of finding the right fit across 5 critical areas of business.

Battling the Big Squeeze

April 23, 2020

Sponsored Content

COVID-19 will impact demand and manifest itself in both top- and bottom-line revenue pressures. And the longer the disruption lasts, the more pressure we will see. These demand and margin pressures are at the core of the “Big Squeeze.”

Three Key Critical Considerations Before Embarking on Decentralized Trials

March 18, 2020

Sponsored Content

- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.